Operational KPIs
No quarterly operational KPIs found in SEC filings for this company.
Citable operating metrics
ABBV's latest SEC-sourced operating KPI table includes Aesthetics Net Revenues Growth Reported at 4929.00 for 2022-03-31.
| Metric | Period | Value | Basis |
|---|---|---|---|
| Aesthetics Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Alphagan Combigan Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Botox Cosmetic Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Botox Therapeutic Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Creon Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Duodopa Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Elahere Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
| Epkinly Net Revenues Growth Reported | Mar 31, 2022 | 4929.00 | quarterly |
Source: SEC EDGAR operating KPI disclosure; period Mar 31, 2022; filed Apr 29, 2022; accession 0001551152-22-000012.
Continue research
Follow same-sector companies and source explainers connected to the kpis view.
A factual guide to operating KPIs — the company-specific metrics in filings, why they are not standardized, and how Aerarium Research surfaces them.
A factual guide to deferred revenue, cash collected before revenue is earned, and why the liability can matter for recurring businesses.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to seasonal revenue patterns and comparable (same-store) sales — why year-over-year comparisons matter and what comp sales strip out.